The use of donation after cardiac death (DCD) donor hepatic allografts is becoming more widespread; however, there have been published reports of increased graft failure from specific complications associated with this type of allograft. The complication of ischemic cholangiopathy (IC) has been repo
Use of Tissue Plasminogen Activator in Liver Transplantation from Donation After Cardiac Death Donors
โ Scribed by K. Hashimoto; B. Eghtesad; G. Gunasekaran; M. Fujiki; T. D. Uso; C. Quintini; F. N. Aucejo; D. M. Kelly; C. G. Winans; D. P. Vogt; B. M. Parker; S. A. Irefin; C. M. Miller; J. J. Fung
- Book ID
- 114805794
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 225 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1600-6135
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Although the use of donation after cardiac death (DCD) donor organs has been shown to be a viable option for liver and kidney transplant recipients, outcomes after simultaneous liver and kidney (SLK) transplantation using DCD donors are less clear. We performed a retrospective analysis of 37 adult,
Hepatitis C virus (HCV) infection is the most common indication for orthotopic liver transplantation in the United States. Although studies have addressed the use of expanded criteria donor organs in HCV รพ patients, to date the use of liver grafts from donation after cardiac death (DCD) donors in HC